MIMS June prescribing update

Fidaxomicin (Dificid) is a novel antibiotic agent and the first of a new class of antibacterials called macrocycles.

It is a narrow spectrum antimicrobial with bactericidal activity against Clostridium difficile (C. difficile), inhibiting RNA synthesis by RNA polymerases.

Fidaxomicin has also been shown to inhibit C. difficile sporulation in vitro.

Latest

Trending